The peanut study involved 31 older adults who ate peanuts during one study period; it did not study therapy or show that therapy changes brain function. Published on October 19, 2026, the study measured a brain blood-flow response to administered insulin, so clinicians describing their work to clients should keep that finding separate from claims about therapy.
The study and a later news account were checked November 15, 2026. They establish what was studied and measured. They do not establish that eating peanuts prevents memory loss or that therapy produces the measured response. Before using a research headline in practice copy, identify the people studied, the intervention and the outcome actually measured.
Key takeaways
- The reported study involved 31 older adults and peanut consumption, not therapy.
- Researchers assessed a brain blood-flow response after administering insulin; that is the reported measure.
- The news account’s memory-performance figure refers to earlier research.
- These sources do not support a claim that peanuts prevent memory loss or that therapy produces the measured brain response.
Who was studied, and what did they do?
The reported study followed 31 older adults, with an average age reported as 67 ± 4 years. In a randomized, single-blind, controlled crossover study, participants consumed 60 grams a day of unsalted, skin-roasted peanuts for 16 weeks or followed a no-peanut control period. An eight-week washout separated the periods, according to the published study.
Those details set the scope of the finding. The intervention was peanut consumption by older adults. The study did not test a therapy service, a clinician’s approach or a way for clients to find care. A clinician who encounters this headline can describe the research accurately without presenting it as evidence for their own practice.
The distinction matters most in short copy, where a reader may see a headline without the study design beneath it. “Researchers studied peanut consumption in older adults” tells the reader what happened. A statement that moves from that finding to what therapy does would make a different claim, one these sources do not establish.
What did the researchers measure?
Researchers assessed brain insulin responsiveness by measuring changes in cerebral blood flow after administering intranasal insulin. They used arterial spin labeling magnetic resonance imaging, or ASL-MRI, for that assessment, as described in the study.
That is a specific reported measure: a brain blood-flow response to administered insulin. It should stay attached to the study population and the peanut intervention whenever the finding is described. The measure does not, by itself, tell a clinician what will happen to a client’s memory. It also does not measure a response to therapy.
For practice writing, the useful question is simple: Does the sentence still name what was actually measured? If “blood-flow response after administered insulin” becomes “better memory” or “better therapy outcomes,” the sentence has moved beyond this reported result. Keeping the measure in plain view gives readers a more accurate account of the research.
Where does the memory figure come from?
The memory-performance figure in the news account comes from earlier research, not from the reported brain-insulin result. The account says that a 2025 investigation found that consuming peanuts for 16 weeks increased overall cerebral blood flow by 3.6% and improved verbal memory performance by 5.8%.
Those figures should not be folded into a description of what the later study measured. The later study assessed a blood-flow response following administered insulin in older adults. The news account places the memory figure in an earlier investigation. Keeping the two findings distinct prevents a reader from mistaking one reported result for another.
Neither page establishes that eating peanuts prevents memory loss. Neither establishes that therapy produces the measured brain response. That is the limit a clinician needs to preserve when deciding whether this research belongs in material meant to help clients understand a practice.
Takeaway
The reported finding concerns peanut consumption and a measured brain blood-flow response in older adults. Clinicians can describe that finding with its population and measure intact, while leaving therapy outcome claims out of it.
If you are in crisis, call or text 988 (US).
Frequently asked questions
Who was studied in the peanut research?
The reported study involved 31 older adults. Participants consumed peanuts during one study period and followed a no-peanut control period during another.
What did the researchers measure?
They assessed changes in cerebral blood flow after administering intranasal insulin, using ASL-MRI. That was the reported measure, not a response to therapy.
Did the study show that peanuts prevent memory loss?
No. The study and the news account do not establish that eating peanuts prevents memory loss. The memory-performance figure in the news account refers to earlier research.
Does the finding support a therapy outcome claim?
No. The intervention in the reported study was peanut consumption by older adults. These sources do not establish that therapy produces the measured brain response.
Sources
- Published study (2026)
- ScienceDaily news account (2026)
This article is general information for clinicians, not legal, billing or clinical advice.
If you're the therapist here.
Your clients get 4 sessions a month. The other 26 days they're on their own. VibeCheck.luxury is the between-session companion that carries those days back to you — clients check in daily, and you walk in already knowing what kind of week it was. Built by Matthew Sexton, LCSW, NATC. VibeCheck.luxury, our practice software, still works. We do not host it today, because hosting costs more than small practices can pay. We would like to release it as open source, so a practice can run it itself.